Posttreatment Head and Neck Cancer Imaging: Anatomic Considerations Based on Cancer Subsites.
Takashi HiyamaYusuke MiyasakaHirofumi KunoKotaro SekiyaShingo SakashitaTakeshi ShinozakiTatsushi KobayashiPublished in: Radiographics : a review publication of the Radiological Society of North America, Inc (2024)
Posttreatment imaging surveillance of head and neck cancer is challenging owing to complex anatomic subsites and diverse treatment modalities. Early detection of residual disease or recurrence through surveillance imaging is crucial for devising optimal treatment strategies. Posttreatment imaging surveillance is performed using CT, fluorine 18-fluorodeoxyglucose PET/CT, and MRI. Radiologists should be familiar with postoperative imaging findings that can vary depending on surgical procedures and reconstruction methods that are used, which is dictated by the primary subsite and extent of the tumor. Morphologic changes in normal structures or denervation of muscles within the musculocutaneous flap may mimic recurrent tumors. Recurrence is more likely to occur at the resection margin, margin of the reconstructed flap, and deep sites that are difficult to access surgically. Radiation therapy also has a varying dose distribution depending on the primary site, resulting in various posttreatment changes. Normal tissues are affected by radiation, with edema and inflammation occurring in the early stages and fibrosis in the late stages. Distinguishing scar tissue from residual tumor becomes necessary, as radiation therapy may leave behind residual scar tissue. Local recurrence should be carefully evaluated within areas where these postradiation changes occur. Head and Neck Imaging Reporting and Data System (NI-RADS) is a standardized reporting and risk classification system with guidance for subsequent management. Familiarity with NI-RADS has implications for establishing surveillance protocols, interpreting posttreatment images, and management decisions. Knowledge of posttreatment imaging characteristics of each subsite of head and neck cancers and the areas prone to recurrence empowers radiologists to detect recurrences at early stages. © RSNA, 2024 Test Your Knowledge questions in the supplemental material and the slide presentation from the RSNA Annual Meeting are available for this article.
Keyphrases
- high resolution
- radiation therapy
- pet ct
- positron emission tomography
- healthcare
- computed tomography
- emergency department
- artificial intelligence
- magnetic resonance imaging
- patients undergoing
- squamous cell carcinoma
- mass spectrometry
- magnetic resonance
- adverse drug
- big data
- fluorescence imaging
- lymph node metastasis
- convolutional neural network
- combination therapy
- pet imaging
- liver fibrosis